DocumentsDate added
Original article
Pujar Chaitra1*, Patil Brijesh2, Nayana KS3
1* Assistant professor, Department of Ophthalmology, S Nijalingappa Medical College and Hanagal Shri Kumareshwar Hospital and Research Center, Navanagar, Bagalkot
2 Associate professor, Department of
Ophthalmology, S Nijalingappa Medical College and Hanagal Shri Kumareshwar Hospital and Research Center, Navanagar,Bagalkot
3 Junior resident, Department of Ophthalmology, S Nijalingappa Medical College and Hanagal Shri Kumareshwar Hospital and Research Center, Navanagar, Bagalkot
Address reprint requests to
*Pujar Chaitra,
Assistant professor, Department of Ophthalmology, S Nijalingappa Medical College and
Hanagal Shri Kumareshwar Hospital and Research Center, Navanagar, Bagalkot.
Article citation: Pujar C, Patil B, Nayana SK. What patients want to know before they undergo cataract surgery: a prospective study. J Pharm Biomed Sci 2015;05(09): 760–764. Available at www.jpbms.info
Purpose: To determine what patients want to know before undergoing cataract surgery in our hospital where most patients come from surrounding rural areas.
Materials and Methods A written questionnaire translated in local language was answered by 200 patients who were booked for cataract surgery.
Results Our study included 54%male and 46% female patients. Information regarding chances of vision improvement, when will the vision improve, overall risk of losing vision
and types of serious complication were given importance. Ninety-eight per cent patients wanted to be warned about complications happening in 1 in 50 and 51% wanted to be warned about complication happening in 1 in 1000. Ninety-eight per cent patients wanted all information verbally explained, only 9.5% wanted to be informed through videos. It was observed in our study that most patients of age 51–60 preferred to get information about the surgery and its complication before surgery. Most female patients felt it was not important to give information about the surgery and its complication.
Conclusion Most patients wanted to know about the chances of vision improvement and serious complications. Female patients wanted the doctor to decide their treatment
and did not desire information prior to surgery which explains illiteracy and ignorance of health in women of rural areas.
KEYWORDS cataract surgery, complications, information, losing vision, risk, rural area,
visual improvement
Statement of originality of work: The manuscript has been read and approved by all the authors, the requirements for authorship have been met, and that each author believes that the manuscript represents honest and original work.
Source of funding: None.
Competing interest / Conflict of interest:
The author(s) have no competing interests for financial support, publication of this research, patents, and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Disclaimer: Any views expressed in this paper are those of the authors and do not reflect the official policy or position of the Department of Defense.
Original article
Peng Yi, Zheng Liu, Zicheng Tan, Gaoxiao Zhang*, Pei Yu**, Yuqiang Wang
Affiliation:
Institute of New Drug Research and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine, Jinan University College of Pharmacy, Guangzhou 510632, China.
The name of the department(s) and institution(s) to which the work should be attributed:
Institute of New Drug Research and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine, Jinan University College of Pharmacy, Guangzhou 510632, China.
Address reprint requests to
* Pei Yu, PhD,
Institute of New Drug Research and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine, Jinan University College of Pharmacy, Guangzhou 510632 China or at pennypeiyu@163.com. Tel.: +8620-8522-5030; Fax: +8620-8522-5030
**Gaoxiao Zhang, PhD,
Institute of New Drug Research and Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine, Jinan University College of Pharmacy, Guangzhou 510632 China or at zhanggaoxiao2005@163.com. Tel.: +8620-8522-4451; Fax: +8620-8522-5030
Article citation: Peng et al. Synthesis and biological Evaluation of Icaritin derivatives. J Pharm Biomed Sci. 2015;05(09):733-739. Available at www.jpbms.info
Original article
Deepti Gulati1*, Mehvish M Nisar2
1 Senior Lecturer, Department of Biotechnology, Dolphin (PG) Institute of Biomedical & Natural Sciences, DehraDun-248007, India
2 Graduate, Department of Biotechnology, Dolphin (PG) Institute of Biomedical & Natural Sciences, Dehra Dun-248007,India
The name of the department(s) and institution(s) to which the work should be attributed:
Department of Biotechnology, Dolphin (PG) Institute of Biomedical & Natural Sciences,
Dehra Dun-248007, India
Address reprint requests to
*Ms. Deepti Gulati. House No. 5/12/3,
Prem Nagar, Dehra Dun, Uttarakhand-248007, India
Article citation: Gulati D, Nisar MM. Isolation and Characterization of Chlorpyrifos Utilizing Bacteria from Sugarcane Field Soil. J Pharm Biomed Sci 2015;05(09):765–770. Available at www.jpbms.info
ABSTRACT: Two chlorpyrifos degrading bacteria were isolated using serial dilution technique followed by selective enrichment on minimal medium with chlorpyrifos as the sole carbon source, from soil samples collected from a sugarcane field in Telpur, Vikasnagar, Dehra Dun, Uttarakhand, India. The isolates were characterized by staining and different biochemical tests. The strains BI01 and BI02 were identified to be Bacillus sp. and Micrococcus sp. respectively. For maximum degradation, the cultures were optimized on different parameters such as incubation time, pesticide concentration, temperature and pH. Microbial growth during the study was monitored by measuring the optical density at
620 nm. Both the isolates showed growth at temperatures ranging from 27°C to 47°C and pH 4.0 to 9.0. The best result for growth of both the isolates was on minimal medium
enriched with 10 ppm chlorpyrifos at temperature 37°C, incubated for 48 hrs at 150 rpm.
The optimum pH for BI01 was found to be 9 and for BI02 was found to be 8. Of the two isolates BI02 showed better results and may possess potential to be used in bioremediation
of chlorpyrifos contaminated environment.
KEYWORDS: Bacillus sp., bioremediation, chlorpyrifos, enrichment, Micrococcus sp.,
optimization
Statement of originality of work: The manuscript has been read and approved by all the authors, the requirements for authorship have been met, and that each author believes that the manuscript represents honest and original work.
Source of funding: None.
Competing interest / Conflict of interest:
The author(s) have no competing interests for financial support, publication of this research,
patents, and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Disclaimer: Any views expressed in this paper are those of the authors and do not
reflect the official policy or position of the Department of Defense.
Majority of the information gathered are from media sources which don’t reflect the author’s
own opinion.
Original article
1,* Natasha Sawhney, 2Pottathil Shinu, 3Bhawna Sharma, 4Varsha A. Singh,
5Tanya Sharma
Affiliation:
1Senior Resident, 2Assistant Professor, 3Post graduate student, 4Professor and head, 5Assistant Professor, Department of Microbiology, Maharishi Markendeshwar Institute of Medical Sciences and Research, Mulllana, Ambala, India-133207
The name of the department(s) and institution(s) to which the work should be attributed:
Department of Microbiology, Maharishi Markendeshwar Institute of Medical Sciences and Research, Mulllana, Ambala, India-133207
Address reprint requests to
* Dr. Natasha Sawhney
Senior Resident
Department of Microbiology, M.M.I.M.S.R., MM University, Mullana, Ambala, India-133207
Article citation: Sawhney, N., Shinu, P.,Sharma, B., Singh, V.A.,Sharma, T. Frequency of Trimethoprim-Sulfamethoxazole And ciprofloxacin resistance among Klebsiellae species isolated from Community-acquired urinary tract infection. J Pharm Biomed Sci. 2015;05(09):750-756. Available at www.jpbms.info
ABSTRACT: Urinary tract infections (UTIs) are common infections affecting all age groups, particularly adults. The present study was carried out to determine the risk factors for trimethoprim-sulfamethaxoazole (TMP-SMX) and ciprofloxacin-resistant Klebsiellae species isolates obtained from community-acquired UTI. A total of 595 patients aged between 15 and 70 years with community-acquired UTI were prospectively recruited; 492 (82.69%) of these samples were sterile. Of the 93 gram-negative isolates included in this study, 56 and 37 isolates were obtained from uncomplicated and complicated UTI, respectively. Since all the male patients were categorized in the complicated UTI group, all 56 non-complicated cases were female patients and 61 (84.72%) of the complicated cases were female patients. The median age was 55 (SD 15.7) and 49 (SD 16) for the uncomplicated and the complicated UTI patients, respectively, and 30.36% and 86.49% of uncomplicated and complicated UTI patients were from a rural area. Klebsiellae species was the causative agent in 83.93% and 67.57% in the uncomplicated and complicated UTI, respectively (P < 0.0174). Nitrofurantoin and fosfomycin were having the resistance ratesof 3.57% and 1.18%, respectively, for uncomplicated UTI strains. Extended spectrum beta-lactamase (ESBL) were detected in 3.6% and 5.66% of the Klebsiellae species isolated from uncomplicated and complicated UTIs, respectively. In summary, TMP/SMX may not be appropriate for the empirical treatment of community-acquired UTI due to its widespread resistance. However, ciprofloxacin may be used warily for both uncomplicated and complicated UTI because of emerging resistance.
KEYWORDS: ciprofloxacin resistance, trimethoprim-sulfamathoxazole resistance, community-acquired urinary tract infection, hospital-acquired urinary tract infection.
Source of funding: None
Competing interest / Conflict of interest: The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Disclaimer: Any views expressed in this paper are those of the authors and do not reflect the official policy or position of the Department of Defense.
Majority of the information gathered are from media sources which don’t reflect the author’s own opinion.
Copyright © 2015 Sawhney, N., Shinu, P.,Sharma, B., Singh, V.A.,Sharma, T. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Case report
Veeranjaneyulu. P1,*, Ajay K Yadlapalli1,¥, Ananth Chintapalli1,€
Affiliation:
1,*MS(ENT), DLO, Professor & Head Department of ENT, 1,¥MS(ENT), Associate Professor,1,€MBBS, Resident, GSL Medical College, Rajahmundry, Andhra Pradesh, India
The name of the department(s) and institution(s) to which the work should be attributed:
Department of ENT, GSL Medical College, Rajahmundry, Andhra Pradesh, India
Address reprint requests to
* Dr. Veeranjaneyulu .P.
Professor and Head, Department of ENT, GSL medical college, Rajanagaram, Rajahmundry, Andhra Pradesh –533 296, India
Article citation: Veeranjaneyulu, P., Yadlapalli, AK., Chintapalli, A. Extranasopharyngeal angiofibroma of maxillary sinus: A rare entity. J Pharm Biomed Sci. 2015;05(09):712-718. Available at www.jpbms.info
ABSTRACT: Nasopharyngeal angiofibromas are rare, benign, non encapsulated tumours originating in the nasopharynx. They constitute only 0.05percent of all head and neck tumours.Histologically similar tumours originating in the sites other the nasopharynx are termed extranasopharyngeal angiofibromas. They are considered as extremely rare tumours. High index of suspicion is very much necessary as they behave clinically different from nasopharyngeal angiofibromas.
Here, we report a case of angiofibroma originating from the maxillary sinus in a 27 year old male patient. Surgical excision was done with complete relief of all the symptoms.
KEYWORDS: angiofibroma; extranasopharyngeal angiofibroma(ENA); maxillary sinus, incidence; vascular neoplasm, excision; biopsy; Nasopharyngeal angiofibroma(NA).
REFERENCES
1.Anna Szymanska, Marcin et al.,Extranasopharyngeal angiofibroma: clinical and radiological presentation, Eur Arch Otorhinolaryngol 2013 February;270(2): 655–660.
2.Veeranjaneyulu.P, Yadlapalli AK et al., Recurrent nasopharyngeal angiofibroma: endoscopic excision, J Pharm Biomed Sci 2015;05(02):104-109. Available at http://jpbms.info/index.php?option=com_docman&task=cat_view&gid=90&Itemid=48.
3.Windfuhr JP, Remmert S, Extranasopharyngeal angiofibroma: etiology, incidence and management. Acta Otolaryngol 2004 Oct;124(8):880-9.
4.Surinder K. Singhal, Nitin Gupta, Hitesh Verma, Arjun Dass, Amarinder Kaur, Extranasopharyngeal angiofibroma: Report of two cases; Egyptian Journal of Ear, Nose, Throat and Allied Sciences 2014;15(1):73–76.
5.I Tasca, G Ceroni Compadretti, Extranasopharyngeal angiofibroma of nasal septum: a controversial entity.; Acta Otorhinolaryngol Ital 2008 Dec; 28(6): 312–314.
6.Lerra S, Nazir T, Khan N, Qadri MS, Dar NH. A case of extranasopharyngeal angiofibroma of the ethmoid sinus: a distinct clinical entity at an unusual site. Ear Nose Throat J 2012 Feb;91(2):E15-7.
7.Windfuhr JP, Remmert S,Extranasopharyngeal angiofibroma of the nasal cavity and paranasal sinuses; Laryngorhinootologie 2004 May;83(5):308-16.
8.Felipe Gustavo Correia , Juliana Caminha Simões et al., Extranasopharyngeal angiofibroma of the nasal septum-uncommon presentation of a rare disease; Braz. J. Otorhinolaryngol. vol.79 no.5 São Paulo Sept./Oct. 2013,
9.G.S.Renukananda, P.K.Basavaraja, A.S.Naik, Mayank Maheshwari, N.K.Balaji,Guhan Thangavelu, Atypical angiofibroma of larynx- a case report; Indian Journal of Otolaryngology and Head & Neck Surgery March 2008;60(1):51-52.
10.P.Karthikeyan, Davis Thomas Pulimoottil, Extra Nasopharyngeal Angiofibroma of the Sphenoid Sinus: A Rare Case Report; IJCRR 2014;6(11):08-13.
11.Marco Antonio Ferraz de Barros Baptista, Fábio de Rezende Pinna, and Richard Louis Voegels; Extranasopharyngeal Angiofibroma Originating in the Inferior Turbinate: A Distinct Clinical Entity at an Unusual Site; Int Arch Otorhinolaryngol 2014 Oct; 18(4): 403-405.
Source of funding: None
Competing interest / Conflict of interest: The author(s) have no competing interests for financial support, publication of this research, patents and royalties through this collaborative research. All authors were equally involved in discussed research work. There is no financial conflict with the subject matter discussed in the manuscript.
Disclaimer: Any views expressed in this paper are those of the authors and do not reflect the official policy or position of the Department of Defense.
Majority of the information gathered are from media sources which don’t reflect the author’s own opinion.
Copyright © 2015 Veeranjaneyulu, P., Yadlapalli, A.K., Chintapalli, A. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.